Victor Maximov

831 total citations
19 papers, 580 citations indexed

About

Victor Maximov is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Victor Maximov has authored 19 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Oncology. Recurrent topics in Victor Maximov's work include Hedgehog Signaling Pathway Studies (3 papers), CAR-T cell therapy research (3 papers) and Epigenetics and DNA Methylation (3 papers). Victor Maximov is often cited by papers focused on Hedgehog Signaling Pathway Studies (3 papers), CAR-T cell therapy research (3 papers) and Epigenetics and DNA Methylation (3 papers). Victor Maximov collaborates with scholars based in United States, Russia and Canada. Victor Maximov's co-authors include Alexey Vertegel, Vladimir Reukov, Б. Р. Чурагулов, Yury V. Kolen’ko, Jin Yu, Yun Xiang, Mark S. Kindy, Guoqi Zhu, Anna Marie Kenney and A. V. Garshev and has published in prestigious journals such as Nature Communications, Blood and Molecular and Cellular Biology.

In The Last Decade

Victor Maximov

19 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor Maximov United States 14 202 142 94 88 86 19 580
Marc Schwarz Germany 13 125 0.6× 82 0.6× 104 1.1× 102 1.2× 208 2.4× 29 760
Daniela Mara de Oliveira Brazil 18 333 1.6× 131 0.9× 278 3.0× 41 0.5× 167 1.9× 42 931
Takuhito Narita Japan 8 175 0.9× 105 0.7× 100 1.1× 28 0.3× 68 0.8× 12 578
Liejing Lu China 19 262 1.3× 199 1.4× 103 1.1× 53 0.6× 234 2.7× 36 933
Yanming Qu China 13 156 0.8× 78 0.5× 48 0.5× 18 0.2× 65 0.8× 41 431
Tatiana O. Abakumova Russia 15 222 1.1× 115 0.8× 31 0.3× 53 0.6× 229 2.7× 37 684
Jung Won Yoon South Korea 18 299 1.5× 185 1.3× 103 1.1× 84 1.0× 104 1.2× 51 889
Ki‐Sung Hong South Korea 11 172 0.9× 229 1.6× 61 0.6× 34 0.4× 61 0.7× 25 671
Kaikai Ding China 15 314 1.6× 385 2.7× 53 0.6× 113 1.3× 60 0.7× 22 969
Jingwei Li China 14 335 1.7× 128 0.9× 20 0.2× 32 0.4× 162 1.9× 21 731

Countries citing papers authored by Victor Maximov

Since Specialization
Citations

This map shows the geographic impact of Victor Maximov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Maximov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Maximov more than expected).

Fields of papers citing papers by Victor Maximov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Maximov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Maximov. The network helps show where Victor Maximov may publish in the future.

Co-authorship network of co-authors of Victor Maximov

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Maximov. A scholar is included among the top collaborators of Victor Maximov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Maximov. Victor Maximov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schuster, Stephen J., Ling‐Yuh Huw, Christopher R. Bolen, et al.. (2023). Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood. 143(9). 822–832. 34 indexed citations
2.
Maximov, Victor, Christopher R. Bolen, Andrew G. Polson, Elicia Penuel, & Elisabeth A. Lasater. (2023). Novel CD20 Mutations As a Mechanism of Resistance to CD20-CD3 Targeted Therapies in Non-Hodgkin's Lymphoma. Blood. 142(Supplement 1). 2808–2808. 1 indexed citations
3.
Sadanand, Arhanti, Victor Maximov, Suttipong Suttapitugsakul, et al.. (2023). Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Reports Medicine. 4(6). 101091–101091. 12 indexed citations
4.
Sadanand, Arhanti, Victor Maximov, Jasmine Lee, et al.. (2021). Abstract 3034: Proteomic profiling identifies PTK7 as a novel immunotherapeutic candidate for neuroblastoma. Cancer Research. 81(13_Supplement). 3034–3034. 1 indexed citations
5.
Schnepp, Robert W., et al.. (2020). YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma. Cancer Research. 80(21). 4741–4753. 14 indexed citations
6.
Maximov, Victor, Zhihong Chen, Yun Wei, et al.. (2019). Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nature Communications. 10(1). 2410–2410. 75 indexed citations
7.
Maximov, Victor, et al.. (2019). Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma. Scientific Reports. 9(1). 18 indexed citations
8.
9.
Herting, Cameron J., Zhihong Chen, Victor Maximov, et al.. (2019). Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. Brain. 142(12). 3834–3851. 49 indexed citations
10.
Wei, Yun, Victor Maximov, A. Sorana Morrissy, et al.. (2018). p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma. Molecular Cancer Research. 17(1). 186–198. 11 indexed citations
11.
Rubin, Binyamin, et al.. (2013). Transport-limited electrochemical formation of long nanosharp probes from tungsten. Nanotechnology. 24(35). 355702–355702. 10 indexed citations
12.
Xiang, Yun, Victor Maximov, Jin Yu, et al.. (2013). Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury. Journal of Cerebral Blood Flow & Metabolism. 33(4). 583–592. 100 indexed citations
13.
Maximov, Victor, Vladimir Reukov, John Barry, Charles G. Cochrane, & Alexey Vertegel. (2010). Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology. 21(26). 265103–265103. 26 indexed citations
14.
Reukov, Vladimir, Victor Maximov, & Alexey Vertegel. (2010). Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents. Biotechnology and Bioengineering. 108(2). 243–252. 27 indexed citations
15.
Vertegel, Alexey, Vladimir Reukov, & Victor Maximov. (2010). Enzyme–Nanoparticle Conjugates for Biomedical Applications. Methods in molecular biology. 679. 165–182. 21 indexed citations
16.
Yurko, Yuliya, et al.. (2009). Design of biomedical nanodevices for dissolution of blood clots. Materials Science and Engineering C. 29(3). 737–741. 22 indexed citations
17.
Maximov, Victor, Vladimir Reukov, & Alexey Vertegel. (2009). Targeted delivery of therapeutic enzymes. Journal of Drug Delivery Science and Technology. 19(5). 311–320. 23 indexed citations
18.
Kolen’ko, Yury V., Victor Maximov, A. V. Garshev, et al.. (2004). Hydrothermal synthesis of nanocrystalline and mesoporous titania from aqueous complex titanyl oxalate acid solutions. Chemical Physics Letters. 388(4-6). 411–415. 77 indexed citations
19.
Kolen’ko, Yury V., et al.. (2003). Synthesis of ZrO2 and TiO2 nanocrystalline powders by hydrothermal process. Materials Science and Engineering C. 23(6-8). 1033–1038. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Schwarz Breakdown of academic impact, for papers by Daniela Mara de Oliveira Breakdown of academic impact, for papers by Takuhito Narita Breakdown of academic impact, for papers by Liejing Lu Breakdown of academic impact, for papers by Yanming Qu Breakdown of academic impact, for papers by Tatiana O. Abakumova Breakdown of academic impact, for papers by Jung Won Yoon Breakdown of academic impact, for papers by Ki‐Sung Hong Breakdown of academic impact, for papers by Kaikai Ding Breakdown of academic impact, for papers by Jingwei Li
Rankless by CCL
2026